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ABSTRACT 
DONGQIUYE PU: Quantitative Structure-Toxicity Relationship Modeling of Organic 
Compounds and Nanoparticles 
(Under the direction of Dr. Alexander Tropsha) 
 
Safety issues are considered the single largest reason for today’s drug 
development failures. It is both costly and time-consuming for toxicological evaluation of 
materials. This dissertation focuses on computational modeling of specific toxicity-
related endpoints against chemical compounds and nanoparticles. We concentrate on the 
application of cheminformatic and QSAR approaches in predicting the toxicity profile for 
small molecules as well as nanoparticles. Extensive efforts have been made in terms of 
data collection, data curation, QSAR modeling and virtual screening of external libraries 
for biologically benign molecules or nanoparticles. 
 Firstly, QSAR analysis has been applied to a group of organic molecules to 
predict their skin sensitization toxicities. Combinatorial QSAR analysis was utilized to 
boost the final model performance. 5-fold external cross-validation and y-randomization 
processes were also applied to validate the robustness of the models. The final models 
achieved prediction accuracy as high as 83% (for both kNN and RF models) after the 
implementation of applicability domain. 
 Secondly, we illustrated successful application of QSAR in modeling 
nanoparticles with two case studies. In both cases, the object datasets consist of 
nanoparticles with same core structure yet different surface molecular modifiers. In the 
first study, computational models were developed for cellular uptake property of a series 
 iv 
 
of nanoparticles possessing same core structure (cross-linked iron oxide) with different 
surface functional groups. Regression models were successfully developed with R02 as 
high as 0.77 with kNN method after the implementation of applicability domain. 
Descriptor analysis suggests that the hydrophobicity of the surface molecule may have 
significant impact on the cellular uptake of iron oxides by pancreatic cancer cells.  The 
second study takes this concept a step further. Besides building statistically significant 
computational models for predicting the protein binding and acute toxicity properties of a 
series of carbon nanotubes, an external chemical library consisting of 240,000 molecules 
were virtually screened in seeking for biologically benign nanoparticles. Moreover, the 
virtual hit list resulting from the virtual screening exercise was shared with our 
collaborators for experimental testing. The final results confirm the high prediction 
accuracy (80% for acute toxicity and 85% for carbonic anhydrase binding endpoint) of 
the established models. This is also the first-ever study in the area of nanotoxicity to 
successfully utilizing computational models for prioritizing nanoparticles for 
experimental testing. 
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Chapter 1.  
 
        Introduction 
 
1.1. Overview 
Although poor pharmacokinetic properties were major causes of attrition in 1990s, 
safety issues are considered the single largest cause for today’s drug development failure [1]. 
Despite of the fact that the in vivo toxicity testing remains the gold standard for identifying 
the side effects induced by a drug, it is now believed that this approach alone could not 
prevent the large failure rate in the late stage of clinical trials. Extensive animal toxicity 
studies will usually not start before the preclinical candidate stage, and human toxicity 
studies will start even later. When one of these studies reveals significant toxicity and causes 
project termination, a significant amount of time has already been spent optimizing the 
potency and the pharmacokinetic profile of the compound, and huge amounts of money have 
been invested in clinical trials. Eventually, all the money and the time invested are 
completely lost. Moreover, under the pressure of reducing the amount of in vivo experiments, 
extensive development of new in vivo test is not an option. It is expected that the right 
combination of in vitro, in vivo and computational toxicology applied as early as possible 
during the drug development process will help reduce the number of safety issues, at least 
enabling to identify poor drug candidates at early stages of the project. 
Toxicity testing is not only challenging for drug candidates, but also for environmental 
agents as well. In recent decades, health protection agencies and the public alike have 
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experienced increasing frustration with the failure of toxicity testing to provide timely, 
relevant information to support informed regulation of environmental agents [2]. Current 
toxicity testing strategies rely primarily on the observation of adverse health responses in 
laboratory animals treated with high doses of these agents. Inferences about risks to human 
populations based on such observations require uncertain extrapolations. As a result, The U.S. 
Environmental Protection Agency (EPA) and the U.S. National Institute of Environmental 
Health Sciences (NIEHS) asked the U.S. National Research Council (NRC) to provide 
guidance on new directions in toxicity testing, incorporating new technologies such as 
genomics and computational systems biology into a new vision for toxicity testing [3]. The 
final report of the toxicity testing committee (NRC, 2007) outlined design criteria for a 
modern approach to toxicity testing. In choosing among various toxicity testing options, the 
NRC committee sought to define a paradigm that would (1) achieve broad coverage of 
chemicals, chemical mixtures, outcomes, and life stages, (2) reduce the cost and time 
required for toxicity testing, (3) develop a more robust scientific basis for assessing health 
effects of environmental chemicals, and (4) minimize use of animals in testing. Inevitably, 
the community promotes expanded use of in silico methods for estimating or predicting 
physical and toxicological properties of compounds from their chemical characterization.  
This dissertation focuses on computational modeling of specific toxicity-related 
endpoints against chemical compounds and nanoparticles. Traditionally, the toxicity models 
were tuned to predict global toxicity endpoints, such as carcinogenicity or mutagenicity [4]. 
However, their broad applicability domain results in lower accuracy, which hampered their 
wide application. It is generally deemed that the lack of accuracy is due to the complexity of 
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the modeled endpoints, rather than to the statistical methods. Therefore, the endpoints that we 
were trying to model in this dissertation are specific and mechanism based.  
1.2. Computational Toxicology  
 Many computational approaches are available to predict the toxicity profile of small 
molecules based on their chemical structures. These approaches generally fall into two major 
categories: expert systems and statistical modeling. Expert systems, such as Derek for 
Windows [5], are a repository of expert knowledge. The computer stores the expert 
knowledge by human experts. Therefore the software performance depends on the time and 
resources devoted by human experts and on the availability of high quality datasets. 
Although the information collected in such systems is usually considered as reliable, 
predictions made by the expert systems typically suffer from poor sensitivity missing side 
effects induced by drugs.  On the other hand, statistical modeling methods, such as 
quantitative structure-activity relationship modeling (QSAR), aim to analyze existing data 
and build objective models reducing the effect of human intervention. The basic assumption 
behind QSAR analysis is that the chemically similar compounds should share similar 
biological or toxicological properties. The k nearest neighbor algorithm developed by Dr. 
Tropsha’s group reflects this philosophy in that it predicts the activity of a compound based 
on its structural similarity with the training set compounds.  
1.3. Quantitative Structure-Activity Relationship (QSAR) 
Previous studies (e.g., SAR analysis) have shown that structural features of small 
molecules impact their physicochemical, biological and toxicological properties. Compared 
with conventional SAR analysis, the QSAR analysis intends to quantitatively explain the 
relationship between chemical structures and the corresponding activity or toxicity. The 
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QSAR analysis is based on the assumption that compounds with similar structures are 
expected to exhibit similar properties (the Similarity Property Principle [6]). This assumption 
serves as a foundation behind experimental SAR studies by medicinal chemists, as well as 
the basis for computational QSAR studies since the 1960s when Dr. Corwin Hansch 
established the very first QSAR analysis to predict chemical solubility. However, the 
definition of similarity is not straightforward because the estimated degree of similarity 
depends on a number of underlying factors such as molecular descriptors, variable selection 
methods, and the similarity metrics. 
To briefly explain the fundamental concepts, any QSAR method can be generally 
expressed in the following form: 
)1.1.........(..........).........,,,(ˆP 21i nDDDk Κ=  
Where Pi is the biological activity of molecule I (dependent variable), D1, D2, …, Dn 
are independent variables, which are either calculated molecular descriptors or 
experimentally measured properties of molecule i, and k(Di) is a function that relate the 
descriptors to the biological activity Pi. k(Di) could be either linear (whose output is directly 
proportional to its input variables) or nonlinear (whose output is not directly proportional to 
its input variables) function, depending on the expected relationship between the descriptor 
values D (input variables) and target property P (output). In essence, all machine learning 
techniques aim to find such mathematical representation of k(Di) that would best reproduce 
the trend in biological or toxicological activities. 
The recent explosive growth of experimental data due to the technological advances in 
High Throughput Screening (HTS) calls for the use of fast QSAR methods to establish 
QSAR models of large and complex data sets. During the past few decades of development, 
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the field of QSAR has grown rapidly in terms of novel molecular descriptors, nonlinear 
regression methods and applications of QSAR to model toxicity and ADME (Absorption, 
Distribution, Metabolism, and Excretion). The differences among various QSAR approaches 
mainly depend on the descriptors used to characterize the molecules and the machine 
learning methods used to establish relationships between input descriptor values and 
biological activities. To list a few popular methods, nonlinear approaches of multivariate 
analysis include the Decision Trees, Random Forest (RF), Artificial Neural Networks (ANN), 
k Nearest Neighbors (kNN), and Support Vector Machines (SVM).  
1.4. Thesis Outline 
 This dissertation focuses on application of cheminformatic and QSAR approaches in 
predicting the toxicity profile for small molecules as well as nanoparticles. Extensive efforts 
have been made in terms of data collection, data curation, QSAR modeling and virtual 
screening of external libraries for biologically benign molecules or nanoparticles. 
 Chapter 2 presents a successful application of QSAR methods in predicting the skin 
toxicity of small molecules tested in in vivo animal model. Allergic contact dermatitis, which 
is the clinical manifestation of skin sensitization, is developed when individuals are 
repeatedly exposed to reactive small molecules. The possible mechanisms of this toxicity 
process have been shown before which laid ground for possible modeling studies. 
Combinatorial QSAR analysis was utilized to boost the final model performance. 5-fold 
external cross-validation and y-randomization processes were also applied to validate the 
robustness of the models. Finally, statistically significant models were applied to an external 
library of chemicals to further prove the usefulness of the models. 
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 Chapter 3 and 4 illustrates successful application of QSAR in modeling nanoparticles, 
which is much more complex than organic molecules. In both cases, the object datasets 
consist of nanoparticles with same core structure yet different surface molecular modifiers. 
This makes it possible to transform the problem to much simpler traditional QSAR problem. 
In chapter 3, computational models were developed for cellular uptake property of a series of 
nanoparticles possessing same core structure (cross-linked iron oxide) with different surface 
functional groups. Regression models were successfully developed to predict the actual 
cellular uptake value tested in the in vitro pancreatic cancer cell line. Chapter 4 takes this 
concept a step further. Besides building statistically significant computational models for 
predicting the protein binding and acute toxicity properties of a series of carbon nanotubes, 
an external chemical library consisting of 240,000 molecules were virtually screened in 
seeking for biologically benign nanoparticles. Moreover, the virtual hit list resulting from the 
virtual screening exercise was shared with our collaborators for experimental testing. The 
final results confirm the high prediction accuracy of the established models. This is also the 
first-ever study in the area of nanotoxicity to successfully utilizing computational models for 
prioritizing nanoparticles for experimental testing. 
  
 
 
 
 
Chapter 2.  
 
Quantitative Structure-Activity Relationship Modeling of Skin Sensitization Tested by 
Local Lymph Node Assay 
 
2.1. Introduction 
 Occupational skin diseases and disorders compose the prevailing categories of 
nontrauma-related occupational illnesses in the United States [7]. These skin diseases include 
contact allergy, contact urticaria, eczema, skin cancer, and other conditions. Among them, 
contact allergy is by far the most common form of occupational skin illness comprising 90-
95% of cases of work-related dermatoses [8]. Allergic contact dermatitis, which is the 
clinical manifestation of contact allergy, is developed when individuals are repeatedly 
exposed to reactive small molecules. It is usually considered as a type IV hypersensitivity 
(delayed hypersensitivity) reaction, which is mediated by T-lymphocytes [7]. Chemicals with 
small molecular weight and appropriate hydrophobicity could penetrate stratum corneum and 
induce local immune response through conjugating with skin proteins. It is widely accepted 
that during the conjugation reaction, small molecules (or their metabolites) act as 
electrophiles, while macromolecules like proteins, act as nucleophiles [9, 10].  
To test the skin sensitization potential of small molecules, several in vivo animal 
models have been developed. The most recently invented local lymph node assay (LLNA) 
could provide both qualitative and quantitative measurements of skin sensitization potency of 
chemicals [11, 12]. Stimulation index (SI) is a quantitative parameter derived from the assay 
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[13], which records the ratio of lymphocytes proliferation induced by tested chemicals 
relative to control experiments. A tested compound can then be classified as a sensitizer if it 
could achieve SI value at least to 3.  
Despite the fact that the animal models could provide a reliable means for testing the 
skin sensitization potential of compounds, it is a remarkably time-consuming and costly to 
screen the large amount of potentially toxic chemicals that exist in the environment. 
Alternatively, computational approaches, such as QSAR or quantitative read across analysis, 
have been employed to build statistical models for screening chemical libraries and prioritize 
suspicious skin toxicants. Quantitative read across analysis tends to simplify the 
interpretation of computational models by merely utilizing the proposed most relevant 
physicochemical properties or substructures to group chemicals. Recently, Enoch and his 
colleagues performed a quantitative and mechanistic read across study of a group of alkenes 
for their skin sensitizing properties [14]. However, challenges were also stated, such as the 
difficulty of calculating chemical reactivity of compounds that was supposed to be critical for 
their skin sensitization potential. Meanwhile, the oversimplified read across models may not 
be able to capture the molecular structures and features contributing to their 
biological/toxicological effects (skin sensitization potential in this case). For regulatory 
purpose, the Organization for Economic Co-operation and Development (OECD) in Europe 
is developing a QSAR toolbox which incorporates multiple toxicological endpoints including 
skin sensitization. QSAR toolbox employs the read-cross method. On the other hand, QSAR 
analysis intends to find quantitative relationship between chemical structures and their 
biological effect (skin sensitization in this case) by applying complex statistical algorithms, 
such as k nearest neighbors (kNN) or random forest (RF). In the field of skin sensitization 
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research, due to good understanding of skin sensitization mechanisms, it was possible to 
develop mechanism-based QSAR models [14-16]. In these studies, chemicals were 
empirically grouped into several clusters according to their mechanism of reaction with 
proteins. Various modeling approaches were then applied to each cluster to generate 
individual skin sensitization model. These models could make predictions for compounds 
whose reactive mechanism were clarified. To make these models more practically useful, a 
recent work was conducted to explicitly classify compounds into specific mechanistic 
applicability domain before mechanism-based models were applied [16]. It stated that 
complicated hierarchical modeling should be employed when utilizing mechanism-based 
models in practice.  
To expand the scope and reduce the complexity of computational models, global 
statistical QSAR models have been developed. In a recent review [15], Patlewicz 
summarized the modeling work completed on skin sensitization before 2007 where statistical 
(global) QSAR models were extensively used. Although global statistical models would less 
likely produce sound mechanistic interpretation than class/mechanism-based models, such 
models have broader potential application in screening and prioritizing toxic compounds for 
regulatory purposes. To make them useful in practice, these models should be thoroughly 
validated. In a very recent work [11], Golla conducted a modeling work on the largest dataset 
at that time and the results held promise in building global model for skin sensitization. 
However, the downside of this research lies in the lack of robust external validation and y-
randomization procedure.  
In this study, we have built global QSAR models of skin sensitization and compared 
their performance in terms of external predictivity with the models developed using read 
 22 
 
across method (as implemented in the ORCD QSAR toolbox). We have applied both kNN 
algorithm, which has been widely investigated in our group [16-19], and RF classification 
algorithm to a dataset of 471 compounds, which was obtained from the 2009 annual report of 
Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) 
program in NIEHS [20]. The results showed that the sensitivity, specificity and correct 
classification rate (CCR) for external validation dataset prediction were 89%, 69% and 79% 
for kNN models and 81%, 73% and 77% for RF models. Both kNN and RF models have 
explicitly incorporated the applicability domain (AD). Furthermore, result of y-
randomization and 5-fold external validation demonstrated the robustness and stability of the 
QSAR models. We also applied the OECD toolbox predictor to make external predictions for 
comparison. The results showed significant advantage of our QSAR models over the OECD 
toolbox in terms of predictive accuracy. In the end, we applied the models to a group of 
chemicals that are suspected to be toxic to skin and sense organs. The result further proves 
the usefulness of the developed QSAR models in prioritizing compounds for toxicity test. 
 
Table 2-1 Number of compounds tested in each individual vehicle. 
Vehicle type No. of Sensitizers No. of Nonsensitizers Total 
ACE 31 14 45 
AOO 178 51 229 
dH2O 2 2 4 
DMF 27 40 67 
DMSO 15 16 31 
PG 8 6 14 
Pluronic L92(1%) 5 2 7 
Others 7 4 11 
Total 273 135 408 
 
Abbreviations: AOO, acetone&olive oil (4:1 by volume); ACE, acetone; DMF, dimethyl 
formamide; DMSO, dimethyl sulfoxide; PG, propylene glycol.  
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2.2. Materials and Methods 
2.2.1. Data Compilation 
The dataset used in this study was obtained from the ICCVAM (Interagency 
Coordinating Committee on the Validation of Alternative Methods) report [20]. An original 
set of 471 compounds in the report was compiled. Structures of chemicals were represented 
by smiles strings, which were retrieved from either PubChem or SciFinder database based on 
Chemical Abstracts Service (CAS) registry number. Chemicals were removed if the 
structures could not be found. Polymers, mixtures, natural products, inorganic salts and small 
gas molecules were also removed standard chemical descriptors could not be computed for 
such substances. In this dataset, the skin sensitization potential was tested based on LLNA, 
and each individual compound was designated as sensitizer/nonsensitizer. Compounds were 
tested in different vehicles to achieve optimal solubility and skin penetration property. Table 
2-1 shows the details regarding the number of compounds tested in each vehicle. There were 
cases where the same compound was tested in multiple vehicles, and they were deleted if 
conflicting classification results based on different vehicles were found. Otherwise, one of 
them was kept. Duplicates were then checked and only one of them was retained if existed. 
After all, 381 (253 sensitizers, 128 nonsensitizers) unique data entries were employed for 
further modeling process. 
Based on previous finding [21] biased modeling set (unbalanced active-to-inactive 
ratio) will result in QSAR models with biased predictivity. To avoid this, we applied a 
dataset balance procedure prior to further modeling. Instead of randomly removing a certain 
proportion of sensitizers from the dataset, we performed a similarity search relying on 
nonsensitizers as a starting point to search the active pool for structurally similar compounds. 
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This exercise was carried out as followed: (1) generate the distance/dissimilarity matrix 
based on the nonsensitizers by calculating Euclidean distance between each pair of 
nonsensitizers; (2) select structurally similar sensitizers based on Euclidean distance between 
each sensitizer to the center of chemical space defined by nonsensitizers.  After this 
procedure, the dataset was reduced to 128 nonsensitizers and 134 sensitizers. 
2.2.2. Dragon Descriptors  
Smile denotation for each compound in the dataset was generated with 
ChemBioDraw software (Ultra, 11.0, Cambridge Software). A set of 2489 theoretical 
molecular descriptors were generated using DRAGON 5.5 software (Talete, Milan, Italy). 
The typology of the included molecular descriptors is: 0D-constitutional descriptors, 1D-
functional group counts, 2D-topological descriptors, 2D-walk and path descriptors, 2D-
connectivity indices, 2D-autocorrelations, 2D-edge adjacency indices, 2D-burden 
eigenvalues, 2D-topological charge indices, 2D-eigenvalue-based indices, 2D-atom-centered 
fragments, 2D-molecular properties, 2D-binary fingerprints and 2D-frequency fingerprints. 
The initial pool of 2489 molecular descriptors was processed as followed: First, descriptors 
that have constant or close to constant values for all modeling set molecules were removed. 
Secondly, redundant descriptors were searched by analyzing the correlation coefficients 
between all pairs of descriptors; if the correlation coefficient between two descriptors was 
higher than 0.99, one of them was removed. After all, the number of dragon descriptors used 
for modeling was reduced to around 700.  
2.2.3. Generation of Training, Internal Test and External Validation Sets 
It has been widely accepted that the external validation is a crucial step of any QSAR 
modeling [22]. Models relying only on training and internal test sets are incapable of proving 
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their robustness and usefulness in virtual screening. Furthermore, the separation of external 
validation set should be independent of any modeling process. Therefore, in this study, the 
external validation set was generated by randomly selecting 20% of compounds in the whole 
dataset, while the rest of them were used as modeling set. Furthermore, to prove the 
consistency of the dataset, external validation process was performed for five times. The 
general principle is that the whole dataset was randomly divided into five subgroups at first, 
and during each time of external validation, one of them was treated as external validation set 
while the remaining four subgroups were combined and used as modeling set. Such exercise 
was repeated for five times so that each subgroup was predicted as external validation set 
once. Specifically in this study, in order to maintain the sensitizer-to-nonsensitizer ratio in 
the external validation set to avoid any bias of statistical results, sensitizers and 
nonsensitizers were separately divided into five subsections and then paired with each other 
to form the final 5 subgroups. Therefore, the sensitizer-to-nonsensitizer ratio in the external 
validation set was the same as in the modeling set.  
Modeling set was further subdivided into multiple training and internal test sets for 
internal validation purpose. Sphere exclusion algorithm developed in our group was 
employed in this study [23, 24]. The procedure implemented in the present study begins with 
the calculation of the distance matrix D between points that represent compounds in the 
descriptor space. Let Dmin and Dmax be the minimum and maximum elements of D, 
respectively. N probe sphere radii, R, are defined by the following formulas: Rmin = R1 = 
Dmin, Rmax = RN = Dmax/4, Ri = R1 + (i–1)*(RN–R1)/(N–1), where i = 2, ..., N–1. Each 
probe sphere radius corresponds to one division in the training and the test set. A sphere-
exclusion algorithm used in the present study consisted of the following steps: (i) randomly 
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select a compound; (ii) include it in the training set; (iii) construct a probe sphere around this 
compound; (iv) select compounds from this sphere and include them alternately into the 
internal test and training sets; (v) exclude all compounds from within this sphere from further 
consideration; and (vi) if no more compounds are left, stop. Otherwise let m be the number of 
probe spheres constructed and n be the number of remaining compounds. Let dij (i=1,...,m; 
j=1,...,n) be the distances between the remaining compounds and the probe sphere centers. 
Select a compound corresponding to the lowest dij value and go to step (ii). This algorithm 
guarantees that at least in the entire descriptor space (i) representative points of the test set 
are close to representative points of the training set (test set compounds are within the AD 
defined by the training set); (ii) most of the representative points of the training set are close 
to representative points of the test set; and (iii) the training set represents the entire modeling 
set (i.e., there is no subset in the modeling set that is not represented by a similar compound 
in the training set) [24]. Consequently, the sphere exclusion algorithm could maximize the 
diversity of the training/internal test sets in the descriptor space used for modeling. Because 
of the stochastic nature of the algorithm, the composition of training and internal test sets is 
different for different original data set divisions. 
2.2.4. k Nearest Neighbors Approach 
The kNN QSAR method employs the kNN classification principle and a variable (i.e., 
descriptor) selection procedure. Briefly, a subset of nvar (number of selected descriptors) 
descriptors is selected randomly at the onset of the calculations. The nvar is set to different 
values, and the training set models are developed with leave-one-out cross-validation (LOO-
CV), where each compound is eliminated from the training set and its category is predicted 
as the averaged category of k most similar molecules, where the value of k is optimized as 
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well (k=1-5). The similarity is characterized by Euclidean distance between compounds in 
multi-dimensional descriptor space. A method of simulated annealing with the Metropolis-
like acceptance criteria is used to optimize the selection of descriptors. The objective of this 
method is to optimize nvar and k values to obtain the best possible LOO-CV correct 
classification rate (CCR) by optimizing the nvar and k. The additional details of the method 
can be found elsewhere. In developing kNN- QSAR models, we followed our general 
predictive QSAR modeling workflow methodology, which places special emphasis on model 
validation. Briefly, we start by dividing the original data set randomly into a (bigger) 
modeling set and a (smaller) external validation set; the latter is not used for model 
development at all, and the former is designated as a modeling set. The modeling set 
compounds are divided multiple times into training and test sets using the Sphere Exclusion 
approach, which ensures that both training and test sets are chemically diverse. The models 
are developed using training set data, and their performance is characterized with the 
standard LOO-CV CCR for the training sets and for the test sets. The model acceptability 
threshold values of the LOO-CV accuracy of the training sets and the prediction accuracy for 
test sets were both set at no less than 0.7. Models that did not meet both training and test set 
cutoff criteria were discarded. Models that passed these threshold criteria were used to 
predict the skin sensitization activity of the external validation set to ensure their external 
predictive power as discussed in the Results and Discussion section. 
2.2.5. Random Forest 
In machine learning, RF is an ensemble classifier that consists of many decision trees 
and outputs the prediction that combines outputs from individual trees. The algorithm for 
inducing a RF was developed by Breiman [25] and Cutler. In this study, we used the R 
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implementation of RF (http://cran.r-project.org/web/packages/randomForest/index.html). 
During the RF modeling procedure, n resamples (number of trees) are constructed from the 
modeling dataset, each of which is obtained by random sampling with replacement 
(bootstrapping method). Each individual tree is built based on m descriptors (arbitrarily 
defined) and optimized using Out-Of-Bag (OOB) estimate of error as target function [26]. In 
each step of modeling generation, the number of descriptors to choose from in each tree node 
is tuned to achieve the lowest OOB estimate of error.  
2.2.6. Validation of QSAR Models  
External validation set, which was randomly selected from original dataset, was used 
to verify the predictive power of QSAR models that have been built. Because multiple 
models were built, consensus prediction technique was used by averaging the predicted value 
from each individual model. Therefore, the predicted value for each compound was a 
continuous number between 0 and 1. Furthermore, 5-fold external cross validation procedure 
was performed against the entire dataset to verify the robustness of the QSAR model.   
2.2.7. Applicability Domain  
Each QSAR model should have an applicability domain (AD) since the model could 
only cover a limited range of the entire chemical space. Specifically in this study, the AD of 
each model is defined by measuring the similarity between compounds in external dataset 
and ones in training set.  
To measure the similarity, the compound is designated as a point in m-dimensional 
space (m is the number of descriptors used in each QSAR model). The molecular 
dissimilarity of any pair of compounds is characterized by quantitating the Euclidean 
distance between their representative points in the multi-dimensional space. For example, for 
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compound i and j, the Euclidean distance between them in M-dimensional space can be 
calculated with the following equation:  
                                              	
  	
 
                                                                        1 
where Xin, Xjn (n=1, …, M) are the values of descriptors for compound i and j. Compounds 
will be considered structurally similar if the Euclidean distance between them is small. 
Therefore, the similarity between external and internal compounds could be determined by 
calculating the Euclidean distance between them. The distance threshold which is used for 
defining AD could be derived as follows:             
                                                                                                  (2) 
where  is the average Euclidean distance between all compounds and their k nearest 
neighbors (k was set to 1 in this process) in the set of nonsensitizers,  is the standard 
deviation of these Euclidean distance, and Z is the tuning parameter to control the similarity 
level. Euclidean distance  between training set compounds and external dataset compounds 
in multidimensional chemical space were calculated and compared with . The compound 
was considered as an outlier if  > .  
For RF algorithm, the chemical similarity was measured with weighted Euclidean 
distances using the equation below: 
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Where  is the weight of the nth descriptor, which is the decrease of predictive accuracy 
when the descriptor values were permuted for all of the modeling set chemicals. 
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2.2.8. Robustness of QSAR Models  
Y-randomization is a widespread technique for validating the robustness of QSAR 
models. It consists of rebuilding the models using randomized activities of the training set 
and subsequent assessment of the model statistics. In this study, standard one-tail hypothesis 
test was used to validate the statistical significance of QSAR models. It is expected that 
models obtained from the training set with randomized activities should have significantly 
lower predictivity than the models built using training set with real activities. If this condition 
is not satisfied, real models built based on this training set are not reliable and should be 
discarded. Specifically for kNN algorithm, 10 split of training and internal test sets were used 
for the test. In each split, activities of training set compounds were reshuffled for 10 times 
and then reassigned to each compound. Then, Z score was calculated based on prediction 
accuracy of internal test set according the following formula: 
                                                                µ /                                                            (4) 
where h is mean prediction accuracy of QSAR model, µ and σ are the mean and standard 
deviation of the prediction accuracy of y-randomization models. For RF algorithm, the 
activities of whole modeling set compounds were permuted for 10 times and then subjected 
to build multiple trees. Z score was calculated based on OOB estimate of error. Both Z scores 
were compared with tabular values of Zc to obtain statistical α value [17]. 
2.2.9. OECD Toolbox 
OECD has carried out a quantitative structure-activity relationships project to facilitate 
practical application of (Q)SAR approaches in regulatory contexts by governments and 
industry and to improve their regulatory acceptance. The goal was to develop a (Q)SAR 
application toolbox which could provide a means of making this technology readily 
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accessible for regulatory use. This toolbox was designed to incorporate a variety of 
information of chemicals from multiple sources and group these chemicals based on their 
molecular structures, features and relevant biological/toxicological effects they exert. Skin 
sensitizing property is one of the endpoints included in the toolbox, and thus enables us to 
make comparison with QSAR models developed in this study. The toolbox was downloaded 
from the OECD website 
(http://www.oecd.org/document/54/0,3343,en_2649_34379_42923638_1_1_1_1,00.html) 
and was implemented according to the introductory material attached to it. The “read across” 
method in the toolbox was applied to make predictions for the same set of external 
compounds used in QSAR model development process. 
2.3. Results and Discussion 
2.3.1. Model Generation and Validation Using kNN and RF Algorithm  
kNN and RF models were developed based on the same modeling set consisting of 
209 compounds. For kNN models, modeling dataset was split into multiple pairs of training 
sets and internal test sets (see Methodology). Models were developed based on training sets 
and were selected by making predictions for compound of internal test tests. Models with 
CCR greater than 0.7 for both training and internal test sets were qualified for further 
validation. Table 2-2 summarizes the information of the top 10 representative models. 
Altogether, the number of models which satisfied the criteria is 220. 
 RF models were developed based on the entire modeling dataset. The number of trees 
built at each modeling step was set at 500. The number of descriptors randomly sampled as 
candidates at each tree was optimized using OOB estimate of error as target function and it 
was set at 64 with OOB estimate of error at 0.27.  
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Table 2-2 Statistical characteristics of the 10 most significant kNN QSAR models 
Model ID Pred. -trn Pred.-test NNN 
1 0.827 0.975 3 
2 0.819 0.962 3 
3 0.819 0.900 3 
4 0.841 0.899 4 
5 0.841 0.899 3 
6 0.834 0.899 3 
7 0.830 0.886 4 
8 0.808 0.886 3 
9 0.878 0.883 4 
10 0.871 0.874 5 
Average 0.838 0.899 4 
 
Abbreviations: N-trn, number of compounds in the training set; Pred.-trn, the overall 
predictivity of the training set; N-test, number of compounds in the test set; Pred.-test, the 
overall predictivity of the test set; NNN, number of nearest neighbors used for prediction. 
 
 External Validation is a critical step of any QSAR analysis. As previous work 
demonstrated [22], no correlation between internal and external predictive power was found. 
In this study, external validation dataset was formed by random selection and was used for 
validation of QSAR models with good internal predictivity. For kNN models, predictions 
were made for these external compounds by all the 220 models which have passed the 
criteria in the model selection process. Consensus predictions were made by averaging the 
predictive values (0 or 1) from individual model. For RF models, predictions were made by 
collecting classifications from all 500 decision trees. Table 2-3 and 2-4 summarize the 
statistical results of external validation for kNN and RF, respectively. As shown in figure 2-1, 
the sensitivity, specificity and CCR of external validation are 0.89, 0.69 and 0.79 for kNN 
and 0.81, 0.73, 0.77 for RF.  
Table 2-3 Results of external dataset validation for 53 compounds with kNN algorithm 
Model 
Characteristics 
Consensus Prediction w/o AD Consensus Prediction With AD 
Exp. Sens. Exp. Non-sens Exp. Sens. Exp. Non-sens 
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Pred. Sens. 24 8 24 5 
Pred. Non-sens 3 18 3 16 
Sensitivity (%) 89 89 
Specificity (%) 69 76 
CCR 79 83 
Coverage (%) 100 91 
 
Table 2-4 Results of external dataset validation for 53 compounds with RF algorithm 
Model 
Characteristics 
Consensus Prediction w/o AD Consensus Prediction With AD 
Exp. Sens. Exp. Non-sens Exp. Sens. Exp. Non-sens 
Pred. Sens. 22 7 21 4 
Pred. Non-sens 5 19 3 15 
Sensitivity (%) 81 88 
Specificity (%) 73 79 
CCR (%) 77 83 
Coverage (%) 100 81 
 
Abbreviations: w/o, without; AD, applicability domain; Exp. Sens., experimental sensitizers; 
Exp. Non-sens., experimental sensitizers; Pred. Sens., predicted sensitizers; Pred. Non-sens, 
predicted non-sensitizers; CCR, correct classification rate. 
 
 
 
 
Figure 2-1 Comparison of kNN and RF in external validation. The modeling and external 
validation set were the same in this comparison. 
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Table 2-5 Examples of improvement of prediction with kNN models after applying the AD 
Compounds Without AD With AD No.Mod ConsPred Pred No.Mod ConsPred Pred 
 
Propylene glycol 
Exp. Cat.: nonsensitizer 
207 0.61 Sensitizer 47 0.47 nonsensitizer 
 
Isopropanol 
Exp. Cat.: nonsensitizer 
177 0.76 Sensitizer 12 0.48 nonsensitizer 
 
Succinic acid 
Exp. Cat.: nonsensitizer 
190 0.72 Sensitizer 29 0.49 nonsensitizer 
 
Abbreviations: AD, applicability domain; Exp.Act., experimental category (0 as non-
sensitizer and 1 as sensitizer); No.Mod., number of models used to make consensus 
predictions; Pred., predicted category. 
 
 Furthermore, to prove the stability of the dataset, 5-fold external cross-validation 
procedure (see Methodology) was performed and the results are shown in Figure 2-2. In the 
case of kNN models, the CCR ranges from 0.72 to 0.83. And for RF models, the CCR ranges 
from 0.73 to 0.83 which also supports the hypothesis that the model was stable. 
2.3.2. Implementation of the Applicability Domain  
 
 
Figure 2-2 Result of 5-fold external cross-validation procedure for kNN and RF QSAR 
models 
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The dataset used for QSAR analysis only covers limited chemical space. Therefore, 
each QSAR model should have a well-defined AD within which reliable predictions could be 
made. In this study, AD was explicitly implemented when applying QSAR models for 
external validation or virtual screening exercise. For both kNN and RF QSAR models, as 
shown on the right part of Tables 2-3 and 2-4, the implementation of AD could increase the 
reliability of prediction (CCR was increased from 0.79 to 0.83 for kNN, and from 0.77 to 
0.83 for RF) at the expense of decreasing the number of compounds for which predictions 
could be made. This was further supported by applying AD in 5-fold external cross-
validation exercise where the implementation of AD could increase CCR for external dataset 
in most cases (figure 2-2). As expected, nearly all the sensitizers fell into the AD of each 
model since most of the structurally dissimilar sensitizers were removed during the data 
balancing procedure. 
2.3.3. Robustness of QSAR Model 
Y-randomization (randomization of activities) was performed to ensure the 
robustness of QSAR models. For kNN algorithm, figure 2-3 shows the correlation of 
prediction accuracy between training set (x axis) and internal test set (y axis) of all models 
generated from both kNN-QSAR procedure and Y-randomization. Standard one-tail 
hypothesis test was performed and Z score was 2.81, which result in α value less than 0.01. 
Subsequently, predictions were made for external compounds using y-randomized models. 
The result showed that sensitivity was 0.5, and specificity was 0.42, with CCR of 0.46. For 
RF models, OOB estimate of error is the target function for optimizing multiple decision 
trees. Z score was calculated to be 5.63 based on OOB estimate of error, which result in α 
value less than 10-6. Predictions were also made for the same external set of compounds 
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which showed that prediction accuracy was 0.44. Therefore, the above results of y-
randomization demonstrate the robustness of both kNN and RF models. 
 
 
Figure 2-3 Statistical distribution of models developed from kNN-QSAR analysis (blue dots) 
and Y-randomization process (red dots). 
 
2.3.4. Comparison of Prediction Accuracy With OECD Toolbox 
To make fair comparison, “read across” models in the OECD toolbox was emplyed to make 
predictions for the same external validation set used in the QSAR model development 
process of this study. The predicted values for each external compound ranged from -1 to 2. 
According to their criteria, compounds 1) with EC3≤10 were assigned to 2; 2) with 
10<EC3≤100 were assigned to 1 and 3) with EC3>100 were assigned to -1. Therefore, we 
were unable to find a threshold to classify compounds according to the predicted values. 
However, figure 2-4 shows the distribution of predicted values for compounds in the external 
set which demonstrates the biased predictivity. Specifically, many nonsensitizers were 
predicted greater than 1 which will lead to low specificity. In regulatory perspective, this will 
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result in high false positive rate while applying this predictor for screening chemical library. 
were labeled differently in these two datasets. Specifically, 1-Bromononane, Tartaric acid, 1-
Bromobutane were labeled as nonsensitizers in ICCVAM report while as sensitizers in 
OECD dataset. These may due to the different experimental protocols adopted by different 
agencies. However, inclusion of these compounds could be potentially risky for QSAR 
model development 
Additionally, by comparing the experimental labels of external dataset compounds 
between OECD dataset and ICCVAM dataset, we found 3 conflictions where compounds  
 
 
 
Figure 2-4 Predictions made by OECD toolbox for the same external validation set used for 
QSAR model development. 
  
-1.0
-0.5
0.0
0.5
1.0
1.5
2.0
2.5
0 3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57
Pr
ed
ic
te
d 
v
a
lu
e 
by
 
O
EC
D
 
to
o
lb
o
x
Compounds in the external validation set
nonsensitizer sensitizer
 38 
 
a. 1-Bromononane Nearest neighbors in the modeling set 
 
 
 
Exp. Cat: nonsensitizer 
(25% could achieve SI of 2.8) 
 
 
 
Exp. Cat: sensitizer 
EC3(%)=19.6 
 
 
 
Exp. Cat: sensitizer 
EC3(%)=17.7 
 
 
 
Exp. Cat: sensitizer 
EC3(%)=9.2 
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EC3(%)=5.1 
b. 2-Acetylcyclohexanone Nearest neighbors in the modeling set 
 
Exp. Cat: 1 
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Figure 2-5 Examples of misclassified compounds in the external set and their nearest 
neighbors in the modeling set. 
 
2.3.5. Investigation of Mis-Classified Compounds in the External Dataset 
For compounds which were incorrectly predicted, it is interesting to investigate their 
nearest neighbors in the modeling set. In this study, eight compounds were mis-classified by 
both kNN and RF models. Figure 2-5 shows two examples of mis-predicted compounds in 
the external validation set and their nearest neighbors in the modeling set. For 1-
Bromononane (compound 19), structurally similar compounds could be found in the 
modeling set which only differ in the number of carbon atoms. Not surprisingly, 1-
Bromononane is predicted as a sensitizer since its nearest neighbors in the modeling set are 
all sensitizers. It is clear from the LLNA data that as the number of carbon atoms increases, 
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the skin sensitization potential will also increase, which is indicated by the decrease of EC3 
value. Actually, in LLNA test, 1-Bromononane could achieve SI to 2.8 when tested in the 
concentration of 25%, which implies that it could be a potential skin sensitizer. 2-
Acetylcyclohexanone, which was predicted as a non-sensitizer, was experimentally classified 
as sensitizer. Its nearest neighbors in the modeling set were also shown in figure 2-5, and 
they are chemically dissimilar with each other, especially in some functional groups. Since 
the reactivity profile of compounds contribute the most to its skin sensitization potential, 
chemicals that differ significantly in functional groups will most likely have distinct skin 
sensitization potential. However, due to the limited chemical space in the modeling set, it is 
unavoidable that not so similar compounds will be considered as nearest neighbors which 
may lead to incorrect predictions. This situation could be possibly resolved when we include 
more data points in proximity to that compound. 
2.3.6. Descriptor Analysis of QSAR Models 
It is important to analyze the descriptors which were considered the most important to 
QSAR models. This analysis could help discovering the molecular features that were most 
relevant to the endpoint being studied. For kNN models, the importance of a descriptor was 
measured by its frequency of occurrence in the statistically significant models. Table 2-6 
shows the names and descriptions of descriptors that were most frequently used among all 
220 kNN-QSAR models developed. Among those, many were related to the presence of 
alkene. The C-C double bond is vulnerable to nucleophilic group presented in proteins, 
especially when neighboring an electron withdrawing group. Also, descriptors B02[C-Cl] 
and B01[C-Cl] describe the chloride neighboring an aliphatic chain that makes the 
neighboring carbon partially positive, which then becomes vulnerable to nucleophiles. This 
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condition was also discussed in another study [10]. Besides, the presence of carboxylic acids, 
esters and hydroxyl groups can also render one carbon electron depleted, which can 
subsequently be approached by electron-enriched amino acid side chains in proteins. As 
previously discussed in the literature [10, 27], several reaction mechanisms including 
Michael additions can be involved in the reaction between haptens and skin proteins. 
Therefore, the presence of electron-depleting functional groups in small molecules is critical 
for their conjugation with proteins 
For RF models, the importance of a descriptor was measured by calculating the mean 
decrease of prediction accuracy when all the values for that specific descriptor were 
permuted [25]. Table 2-7 lists the descriptors that were considered the most important to RF 
model. In this case, molecular features such as polar surface area, hydrophilic factor, 
electronegativity were considered critical in categorizing compounds towards skin 
sensitization endpoint.  
Table 2-6 Descriptors used most frequently in the kNN-QSAR models 
Descriptor Name Frequency of Occurrence(%) Description 
nCconj 15 Number of non-aromatic 
conjugated C (sp2) 
B02[C-Cl] 14.1 
 
presence/absence of C-Cl at 
topological distance 02 
B01[C-Cl] 13.2 presence/absence of C-Cl at topological distance 01 
nRCOOR 11.8 number of esters (aliphatic) 
TPSA(NO) 11.4 topological polar surface area 
using N,O polar contributions 
nR=Cs 9.5 number of aliphatic secondary C(sp2) 
nRCOOH 9.1 number of carboxylic acids (aliphatic) 
nROH 8.6 number of hydroxyl groups 
Me 8.2 
mean atomic Sanderson 
electronegativity (scaled on 
Carbon atom) 
C-041 7.3 X-C(=X)-X 
C-019 6.4 (=CRX) 
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Table 2-7 Descriptors considered important in RF-QSAR models 
Descriptor Name Mean Decrease Accuracy Description 
AAC 1.72 Mean information index on 
atomic composition 
TPSA(NO) 1.65 Topological polar surface area 
using N, O polar contributions 
SEige 1.30 Eigenvalue sum from 
electronegativity weighted 
distance matrix 
DELS 1.13 Molecular electrotopological 
variation 
SEigv 1.07 Eigenvalue sum from van der 
Waals weighted distance matrix 
ZM1V 1.05 First Zagreb index by valence 
vertex degrees 
Hy 1.04 Hydrophilic factor 
IC1 1.00 Information content index 
(neighborhood symmetry of 1-
order) 
MAXDN 0.89 Maximal electrotopological 
negative variation 
MATS2v 0.83 Moran autocorrelation – lag2 / 
weighted by atomic van der 
Waals volumes 
Me 0.82 Mean atomic Sanderson 
electronegativity (scaled on 
Carbon atom) 
 
Therefore, the analysis of molecular descriptors in statistically significant and 
externally predictive models reveals important chemical features contributing to skin 
sensitization potential. In agreement with the previous findings, descriptors reflecting the 
presence of electron-depleting carbons showed up frequently. Besides, descriptors which 
capture the overall physical property and reactivity also present supporting the fact that the 
reactivity of molecules is a major contributing factor related to chemicals’ skin sensitization 
potential. 
2.3.6. Application of QSAR Models to a Dataset Including Possible Skin/Sense Organ 
Toxicants 
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To further apply the QSAR models developed in this study and to prove their 
usefulness, we performed a second external prediction exercise. We obtained a dataset from a 
website called “Scorecard” which compiles environmental chemicals suspicious to be skin 
and sense organ toxicants (http://www.scorecard.org/health-effects/chemicals-
2.tcl?short_hazard_name=skin&all_p=t). Altogether, 786 chemicals along with their CAS 
registry numbers were collected. After removing molecules that we could not calculate the 
descriptor values for, 607 chemicals were employed for the prediction exercise. Every 
compound from this dataset has evidence from multiple sources where it was found to be 
potentially toxic. To further confirm the evidence, we checked the experimental classification 
of compounds from “Scorecard” which have already been tested by LLNA methods (in fact, 
143 chemicals on “Scorecard” were already included in the ICCVAM report). By checking 
their experimental classifications, we found that 130 of them were sensitizers while the rest 
13 were nonsensitizers. From this, we assumed that more than 90% of the compounds 
included on “Scorecard” were skin sensitizers. The results (figure 2-6) showed that after 
removing the structural outliers, approximately 75% of the molecules were classified as 
potential skin sensitizers when applying kNN and RF QSAR models respectively (182 out of 
242 for kNN, 175 out of 227 for RF). Therefore, the results of the second external dataset 
prediction have further proved the usefulness of the QSAR models in prioritizing compounds 
with potential skin toxicity.  
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Figure 2-6 Apply both kNN (a) and RF (b) QSAR models for predicting the skin sensitization 
potential of compounds in the second external dataset. 
 
2.4. Conclusions 
In this study, we employed conventional QSAR approach to analyze the relationship 
between small molecule structures and their skin sensitization potentials tested by the LLNA 
method. After data curation, QSAR modeling based on the remaining 262 compounds using 
kNN and RF statistical algorithms showed good performance on both internal test set and 
external validation set. The robustness and predictivity of QSAR models were subsequently 
validated by y-randomization and 5-fold cross-validation procedure. Applicability domain of 
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QSAR models’ for both methods was explicitly defined and implemented during both 
external dataset prediction exercises. Also, we identified descriptors which were considered 
important in the modeling process. This information further enhances our understanding 
towards the relationship between molecular structure and skin sensitization endpoint.  
Validated models were applied to a set of chemicals, which are likely to be toxic to skin 
and sense organs. Approximately 75% of the chemicals were tagged as potential toxicants by 
QSAR models, which proves their accuracy and usefulness. Therefore, the QSAR models 
developed in this study could be further used to screen chemicals used in cosmetics and 
research labs where the skin toxicity of chemical reagents is a big concern. 
 
  
 
 
 
Chapter 3.  
 
Modeling of MNPs’ Uptake in PaCa2 Cancer Cells 
 
3.1. Introduction 
More than 1000 manufacturer-identified nanotechnology-based consumer products are 
now available on the market. Green nanotechnology is particularly in demand to develop 
efficient and less-polluting energy sources. However, at least some Manufactured 
NanoParticles (MNPs) intended for industrial applications are suspected to have potential 
toxicities in humans [28, 29] and the public concern about the safety of MNPs is on the rise. 
Biological effects could result from exposure and subsequent absorption of ultrafine MNPs 
via different routes [30]. Understanding the effects of systemic exposure to MNPs is of 
paramount importance since such exposure may result in their potentially detrimental 
delivery to critical organs. MNPs gaining entry into the systemic circulation can immediately 
interact with blood cells and then be either distributed throughout the body, or captured 
quickly by macrophages of the reticuloendothelial system. Acute or repeated exposure to 
MNPs present in commercial products may thus potentially cause systemic, cellular, and/or 
genomic toxicities.  
Experimental nanotoxicology is a very young field [31-35]. There remain significant 
scientific gaps in our understanding of the toxicology of nano-based materials that are, (i) 
already contained in commercial products that are not intended for human exposure, (ii) 
could contaminate the environment while also not intended for human exposure, and (iii) 
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intended for biomedical applications such as drug delivery, imaging, and sensing. Regardless 
of the source or intended application of the nanomaterial, it is imperative that we develop a 
much more comprehensive and hopefully predictive knowledge of the effects of these 
nanomaterials on environment as well as animals and human beings. Although some data 
exist on the absorption properties and associated toxicities of certain types of NPs after 
exposure via the pulmonary, oral, and topical routes, little is known about the systemic 
distribution, metabolism, elimination, and health effects once the particles reach the systemic 
circulation. There were several reports on the deleterious effects of manufactured and 
environmental NPs on humans and wildlife. For instance, Radomski et al. [36] reported that 
both multi-wall and single-wall carbon nanotubes caused platelet aggregation and accelerated 
vascular thrombosis. Harhaji et al. showed that even at the ‘high dose’ of 1 ug/mL, the C60 
fullerenes caused reactive-oxygen species-mediated necrotic cell damage [37] and thus 
proposed C60 fullerenes as an anti-cancer agent [38]. Kane et al. found that silica NPs 
directly interacted with plasma and lysosomal membranes leading to Ca2+ influx, ATP 
depletion, and cell death [39]. Kang et al. observed that nano-TiO2 caused ROS stress and 
DNA damage in lymphocytes [40]. Leonard et al. showed that PbCrO4 particles resulted in 
ROS generation and upregulation of NF-kappaB and AP-1 in RAW 264.7 cells [41]. 
Pulskamp et al. reported that several carbon NPs (multi-walled, single-walled, carbon black, 
quartz) increased ROS and decreased mitochondrial membrane potential in a dose- and time-
dependent manner in rat macrophages and human A549 lung cells [42]. Donaldson et al. also 
investigated some carbon nanotubes [43] that reached the lungs of mice which have inhaled 
NPs. A remarkable review on the subject of nanotoxicity was recently published [44] listing 
a few examples of known toxic effects of MNPs. 
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 There are numerous difficulties in modelling nanoparticles. First, the availability of 
data concerning MNPs is sparse in the public domain, making difficult the development and 
the validation of computational models requiring relatively large amounts of data to obtain 
reasonable predictive abilities. Moreover, because of the high structural diversity of MNPs, it 
is a real challenge to develop quantitative parameters that are able to characterize the 
structural and chemical properties of MNPs. Systematic physico-chemical, geometrical, 
structural and biological studies of NPs are nearly absent due to practical and commercial 
issues. Therefore computational modeling of nanoparticles is only beginning to emerge and 
first attempts suggest that successful modeling studies will only be realized in close 
collaboration with experimental scientists. To the best of our knowledge, computational 
nanotoxicology is almost non-existent. Most likely, the comprehensive computational 
nanotoxicology effort would require the integration of several computational techniques such 
as quantum mechanics, molecular dynamics simulations [44-47] and cheminformatics [47, 
48]. For instance, Liu et al. clearly demonstrated the usefulness of molecular dynamics 
simulations (i) to reveal the overall changes in the structure of cellular membranes caused by 
the insertion of carbon nanotubes [45] as well as (ii) to estimate the affinity of drug-like 
molecules to carbon nanotubes in an aqueous environment [46]. In another recent study by 
Shaw et al. [49], 51 MNPs have been thoroughly tested in vitro against four cell lines in 
different assays to study the biological effects induced by these particles. Different common 
statistical techniques have been applied in order to find the correlations between the activity 
profiles of nanomaterials, and thus, to discover some hidden structure-property relationships. 
It is fully expected that, similar to other more traditional materials based on organic 
molecules, the experimental body of knowledge concerning the biological effects of MNPs 
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will substantially increase in the near future. An example of a planned large scale study is 
provided by the joint project between EPA, NIEHS, and the NIH Chemical Genomics 
Center. We believe that similar to other chemical and biological disciplines, the application 
of high-throughput assay technologies to test nanoparticles will become increasingly popular 
in the near term, resulting in a lot of new data and thus enabling large-scale modeling.  
Recently, Puzyn et al. [47] advocated for the utiliy of QSAR modeling as an 
important computational nanotoxicology approach. The authors illustrated the structural 
diversity of nanomaterials and concluded that no universal "nano-QSAR" model can be build 
to assess the toxicity of all possible nanoparticles. Puzyn et al. also emphasized the need of 
experimentally measured parameters such as the size of particles and suggested using these 
parameters as valuable variables for the modelling. In the last part of their review, the authors 
report a few QSAR models mainly developed for carbon nanotubes and fullerenes to assess 
either their solubility or lipophilicity. However these multi-linear models were developed 
using very small datasets (usually less than 20 particles) and were not validated according to 
rigorous statistical methods. Up to now, there have been no significant studies for large 
experimental nanoparticle datasets to model their induced biological effects and validate 
these models with external predictions. 
The main objective of the work in this chapter is to develop predictive Quantitative 
Nanostructure-Activity Relationships (QNAR) or Quantitative Nanostructure-Toxicity 
Relationships (QNTR) following the same principles of classical QSAR workflows [50]. 
However, due to the lack of appropriate theoretical descriptors and available three-
dimensional structures, we proposed to build hybrid models involving a combination of 
experimentally measured and novel calculated descriptors (see Figures 3-1 and 3-2). The 
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overall objective of QNAR models is to relate a set of NP descriptors to a given target 
property like their potential toxicity (expressed as a binary property: toxic vs. non-toxic) or 
their cellular uptake (expressed as a continuous value). Such models could then be applied to 
newly-designed or commercially available NPs in order to quickly and efficiently assess their 
potential biological effects. It is of importance to notice that QSAR models are not "magic 
bullets" at all: the more data we can access to build and validate our models, the more 
efficient and accurate they will be.
 
Figure 3-1 Comprehensive modeling of nanostructure-toxicity relationships (QNTR) using 
physical/chemical and/or computed descriptors, cell based assays, or a combination of both 
to predict in vitro activities and ultimately, human effects of MNPs. (Courtesy of Dr. Denis 
Fourches) 
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Figure 3-2 QSAR modeling of NP biologic profiles using mixed fingerprints, involving both 
experimentally measured as well as computationally calculated descriptors (see the text for 
details). (Courtesy of Dr. Denis Fourches) 
 
As a proof-of-concept, we describe a case study that involves a series of nanoparticles 
that have been tested for their effects in different in vitro cellular based assays. The series [51] 
includes 109 NPs with the same core but different surface modifiers. We have applied 
conventional cheminformatics techniques such as QSAR modeling to establish quantitative 
links between available nanoparticle descriptors and their biological profiles; by analogy 
with QSAR we termed the latter approach QNAR where the letter “N” stands for 
nanoparticles. The case study could be regarded close to a conventional QSAR study since 
109 nanoparticles had the same core and therefore they were characterized by conventional 
chemical descriptors calculated for each organic compound used as surface modifiers. In this 
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study our QNAR calculations led to validated and externally predictive models: these models 
relate quantitatively the chemical, physical and geometrical properties of MNPs with their 
biological effects measured in vitro in different assays for diverse cell lines. We believe that 
this study, which to the best of our knowledge was then the first QNAR analysis of relatively 
large datasets, successfully demonstrates the high potential of cheminformatics approaches to 
improve experimental design and prioritize toxicity testing of novel MNPs. 
3.2. Materials and Methods 
3.2.1. Datasets 
Weissleder et al. [49] recently investigated whether the multivalent attachment of 
small organic molecules into the same nanoparticles can increase their specific binding 
affinity to certain cells and thus have high potential for use in biomedical applications to 
target certain cell lines specifically. The authors achieved the parallel synthesis of a library 
comprising 109 nanoparticles (Cross-Linked Iron Oxide with amine groups, CLIO-NH2) 
decorated with different synthetic small molecules. Nanoparticles were made magneto-
fluorescent with the addition of FITC (fluorescein isothiocyanate) molecules on their 
surfaces to enable their cellular measurement. This library of fluorescent magnetic particles 
was screened against different cell lines: PaCa2 human pancreatic cancer cells, U937 
macrophage cell line, resting and activated primary human macrophages, and HUVEC 
human umbilical vein endothelial cells. Unlike the other cell lines, the PaCa2 pancreatic 
cancer cells showed very diverse cellular uptakes for the different NPs enabling the 
application of QSAR modeling approach to this data. 
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3.2.2. QSAR Modeling 
Cheminformatics technologies such as QSAR modeling are widely applied in modern 
drug discovery workflow. Fundamental principles behind QSAR modelling were reviewed in 
the introductory chapter. 
To quantify the relationships between chemical descriptors and a given property (e.g., 
binding affinity, aqueous solubility, cellular toxicity etc), QSAR modeling employs complex 
machine leaning algorithms (such as Support Vector Machines or the k Nearest Neighbors) 
that take as inputs the descriptor matrix of compounds and output a predicted value for the 
modeled property. Our group recently published a detailed description of a predictive QSAR 
workflow [50] as well as various applications of QSAR modelling [52-54]. 
The QSAR modeling workflow can be divided into three major steps: data 
preparation (selection of compounds and descriptors), data analysis (methods), and model 
validation (including the evaluation of its Applicability Domain – AD). Practically, an 
ensemble of curated compounds for which experimental activity is known, is randomly split 
into several training and test sets. Models are built using the training set compounds only, 
and then applied to assess the properties of test set compounds. One of the major goals of a 
QSAR procedure is to minimize the error between predicted and observed activities. 
Thereafter, according to rigorous tests (leave one-many out, n-fold Cross-Validation, Y-
randomization etc.) and well defined statistical parameters expressing the robustness and 
accuracy, certain models are selected if they have reasonable prediction performances both 
for the training (assessed by cross-validation procedures) and test sets [22]. On the last stage 
of calculations, those selected models are applied to the external validation set compounds in 
order to predict their properties.  
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We used different statistical parameters to evaluate the performance of models. For 
binary classification problem (like case study 1 – see section 3.1), they are defined as: 
Accuracy = (TP + TN) / (NA + NI)      (1) 
Sensitivity = TP / NA        (2) 
Specificity = TN / NI        (3) 
CCR = 0.5 (Sensitivity + Specificity)      (4) 
Where NA is the total number of actives (or class 1), NI is the total number of inactives (or 
class 0), TP is the number of true positives (experimentally actives predicted as actives), TN 
is the number of true negatives (experimentally inactives predicted as inactives), CCR is the 
Correct Classification Rate. 
For continuous activities, we used R2abs (squared correlation coefficient – for test set 
compounds), Q2abs (squared leave-one-out cross-validation correlation coefficient – for 
training set compounds) and MAE (mean absolute error) for the linear correlation between 
predicted (Ypred) and experimental (Yexp) data (here, Y = Paca2 cellular uptake); these 
parameters [22, 54] are defined as follows: 
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The regression models were considered acceptable if Q2abs > 0.6 and R2abs > 0.6. 
Y-randomization (randomization of response) is a widely used approach to establish 
the model robustness. It consists of rebuilding the models using randomized activities of the 
modeling set and subsequent assessment of the model statistics. It is expected that models 
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obtained for the modeling set with randomized activities should have significantly lower 
predictivity for the external validation set than the models built using modeling set with real 
activities. If this condition is not satisfied, models built for this modeling set are not reliable 
and should be discarded. This test was applied to all data divisions considered in this study. 
3.2.3. Chemical Descriptors 
To enable their computational treatment, chemical structures are represented by 
descriptors that are calculated solely from both composition and connectivity between atoms. 
Thousands of descriptors can be calculated using many public or commercial software 
packages; most popular descriptors include constitutional (e.g., number of oxygen atoms in 
the molecule), geometrical (e.g., total surface area, molecular volume), topological (e.g., 
average vertex degree, Kier & Hall indices), fragmental (e.g., number of fragments C-C-O, 
number of rings), electrostatic, etc. Additional information about chemical descriptors can be 
found elsewhere [55].  
Molecular Operating Environment (MOE) [56] is one of the commercially available 
software that affords computation of a wide range of chemical descriptors of molecular 
structures. In our case study, we used so called two-dimensional (2D) MOE descriptors 
including physical properties, surface areas, atom and bond counts, Kier & Hall connectivity 
indices, kappa shape indices, adjacency and distance matrix descriptors, pharmacophore 
feature descriptors and molecular charges.  
3.2.4. k Nearest Neighbor Regression Analysis 
The kNN QSAR method [17, 57] is based on the idea that the activity of a given 
compound is predicted by averaging the activities of k compounds from the modeling set 
which are considered as its k most chemically similar neighbors. Briefly, our algorithm 
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employs the kNN classification principle and the variable selection procedure: it generates 
both an optimum k value and an optimal nvar subset of descriptors that afford a QSAR 
model with the highest training set model accuracy as estimated by the Q2abs statistical 
parameter. A subset of nvar (number of selected variables) descriptors is selected randomly 
at the onset of the calculations. The nvar is set to different values, and the training set models 
are developed with Leave-One-Out cross-validation, where each compound is eliminated 
from the training set and its biological activity is predicted as the average activity of the k 
most similar molecules, where the value of k is optimized as well (k = 1-5). The similarity is 
characterized by the Euclidean distance between compounds in multidimensional descriptor 
space. A method of simulated annealing with the Metropolis-like acceptance criteria is used 
to optimize the selection of variables. The objective of this method is to obtain the best leave-
one-out cross-validated Q2abs possible by optimizing nvar and k. The additional details of the 
method can be found elsewhere [50]. 
3.2.4. Applicability Domain 
Every QSAR model is closely linked to its training set in such a way that its ability to 
extrapolate outside the region of the chemical space defined by this training set is not 
obvious to assess. The Applicability Domain (AD) of a model is defined in order to 
determine if a given model could or could not be applied to predict the activity of a query 
compound [50-53]. Formally, a QSAR model can predict the target property for any 
compound for which chemical descriptors can be calculated. However, if a compound is 
dissimilar from all compounds of the modeling set, its predicted activity is unreliable. In this 
study, the AD was defined as a threshold distance DT between a query compound and its 
closest nearest neighbors in the training set, calculated as follows: 
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σZyDT +=     (4) 
where y  is the average Euclidean distance between each compound and its k nearest 
neighbors in the training set (where k is the parameter optimized in the course of QSAR 
modeling and the distances are calculated using descriptors selected by the optimized model 
only), σ is the standard deviation of these Euclidean distances, and Z is an arbitrary parameter 
to control the significance level. We set the default value of this parameter Z at 0.5, which 
formally places the allowed distance threshold at the mean plus one-half of the standard 
Table 3-1 QSAR modeling of PaCa2 cell uptake for 109 MNPs with different surface 
attachment. 
Fold Modeling Set 
External 
Set 
# 
models 
No Applicability 
Domain With Applicability Domain 
R2abs MAE R2abs MAE 
Coverage 
(%) 
1 87 22 371 0.65 0.18 0.67 0.18 86 
2 87 22 282 0.67 0.14 0.73 0.13 91 
3 87 22 266 0.72 0.22 0.75 0.21 82 
4 87 22 183 0.75 0.19 0.9 0.14 64 
5 88 21 145 0.8 0.16 0.78 0.17 76 
 0.72 0.18 0.77 0.17 80 
 
deviation. Thus, if the distance of the test compound from any of its k nearest neighbors in 
the training set exceeds the threshold, the prediction is considered unreliable. The detailed 
description of the algorithm to define the AD is given elsewhere [50]. 
3.3. Results and Discussion 
All NPs included in the dataset possessed exactly the same metal core. As a result, 
each particle was then represented by a unique organic compound that was chemically bound 
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to its surface. MOE descriptors were calculated for all these 109 organic compounds. Overall, 
150 MOE descriptors were selected after the removal of descriptors with zero variance and 
highly correlated ones. Cellular uptakes were expressed as the logarithms of the numbers of 
particles per cell and varied from 2.23 to 4.44. Next, classical QSAR investigation was 
performed along with descriptor analysis trying to uncover major attributes responsible for 
cellular uptake. External 5-fold cross validation exercise was carried out as in the case study 
1, but employing k Nearest Neighbors (kNN) approach as modeling technique. Results 
showed that prediction performances expressed as absolute coefficients of correlation R2abs 
ranged from 0.65 to 0.80 for each fold external set (see Table 3.1). These results were 
slightly improved (0.67~0.90) by taking into account the applicability domain of models and 
thus removing compounds that are outside models' AD. Y-randomization procedure was also 
performed and no statistically significant model was retrieved, proving the robustness of 
QSAR models built on this dataset. To analyze the descriptors being involved in statistically 
significant models, we investigated the most frequently used descriptors and their average 
values in nanoparticles showing the highest and the lowest cellular uptakes (see Figure 3-
3(a)). Significant differences between top 20 (highest uptake) and bottom 20 (lowest uptake) 
nanoparticles were revealed by this analysis. Lipophilicity was found to be the most 
  
 58 
 
 
(a)                                                                 (b) 
 
Figure 3-3 Analysis of descriptors used most frequently in kNN-QSAR models of 109 
nanoparticles. (a) Average descriptor values in MNPs with highest and lowest PaCa2 cellular 
uptakes. (b) Example of a lipophilicity related descriptor (GCUT_SLOGP_0) significantly 
discriminating particles with highest and lowest PaCa2 cellular uptakes. 
 
determinant factor that discriminates between particles: several descriptors like 
GCUT_SLOGP_0, SlogP_VSA0, BCUT_SLOGP_0, and SlogP_VSA1 are expressing 
particles' lipophilicity. As one could expect, particles with lipophilic surface modifiers are 
likely to have higher cellular uptake (see Figure 3-3(b)). However this phenomenon is only 
found in Paca2 cell lines. In the other cell lines tested by Weissleder et al. [51], cellular 
uptakes measured for the same series of NPs did not reveal such significant variations as a 
function of particle structural properties. Other descriptors like molecular refractivity 
(GCUT_SMR_0), specific Van der Waals surface area (basic vsa_base, acidic vsa_acid, and 
donor vsa_don), and electrostatic descriptors can distinguish between particles possessing 
high or low Paca2 cellular uptakes. Additional investigations are in progress to map these 
discriminative properties on structures and detect key structural fragments that most 
influence the cellular uptake. These findings imply that a rational design of organic 
compounds attached to the surface of nanoparticles is possible using QSAR models and 
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descriptor analysis. Overall, models assessing the potential cellular uptake for particular cell 
lines may be of high importance to design novel cell-targeting particles that can deliver drugs 
to these cells specifically. We believe this study is the first example of successful QSAR 
modeling of NP cellular uptakes. Additional studies are currently in progress in our 
laboratory to develop models for other cell lines and particles. We aim to develop an 
ensemble of models that could be used as efficient filters for computer-aided nanoparticle 
design and thus prioritize synthesis of NPs with the desired biological profiles. 
Challenges of computer-aided nanotoxicology are numerous because of the complex 
nature of nanoparticles. Although QSAR methodology is well known and has been massively 
applied in the areas of drug discovery [50] and chemical toxicity modelling [54], its 
application to model the biological effects of nanoparticles presents a real challenge for 
several reasons: 
(1) NPs are complex assemblage of inorganic and/or organic elements and sometimes, 
mixed or coated with diverse organic compounds (the exact stoichiometry varying 
from one particle to another); classical molecular descriptors are thus not appropriate 
any more.  
(2) The composition of a given MNP is not exactly known or may not correspond to the 
information provided by the vendors. 
(3) Three-dimensional nanostructures including thousands of atoms are highly complex. 
Many computational approaches (like ab initio quantum chemistry methods) where it 
is challenging even to handle small drug-like organic compounds cannot treat such 
large systems at all.  
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This high structural diversity of MNPs as well as the sparse availability of data on structure 
and biological activity of nanoparticles in the public domain makes difficult the development 
and validation of computational QNAR models. Systematic physico-chemical, geometrical, 
structural and biological studies of NPs are nearly absent. Therefore computational modeling 
of nanoparticles is only beginning to emerge but some studies already pointed out the 
usefulness of molecular dynamics simulation and QSAR modeling [45-47] to assess 
biological properties of MNPs. A public database comprising all available data concerning 
nanoparticles from their chemical characterization to their experimental testing results would 
definitely help to initiate and/or speed up the development of current and future researches in 
computational nanotoxicology. 
The overall goal of our research is to demonstrate the potential benefits of using 
cheminformatics approaches such as QSAR modeling to obtain predictive knowledge of the 
chemical, physical, and geometrical properties of MNPs that affect human cells and utilize 
this knowledge for improved MNP experimental design and prioritized toxicity testing. There 
are four fundamental hypotheses that drive this research study: 
 (1) The effects of MNPs on different types of human cells depend on the 
physical/chemical/geometrical properties of the MNPs: this implies that all such properties, 
i.e., composition, size, shape, aspect ratio, surface area, chemistry/morphology, zeta potential, 
chemical reactivity, structural descriptors should be explicitly experimentally characterized 
and/or computed (if possible) in order to understand their individual or combined 
contributions that define the biological effects of MNPs. Materials at the nano-scale may 
have very different properties in comparison to the same material at the micron or macro 
scale. However, the field has been constrained by the lack of rationalization of possible 
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relationships between these properties and the resulting biological endpoints including 
toxicity. Confounding this problem is that MNPs often have properties different than those 
stated on Certificate of Analysis, and further, these MNPs often undergo 
aggregation/agglomeration in the presence of salts/buffers/media used in the biological 
assays. 
 (2) High-throughput cellular-based assays with endpoints within 2-6 hours provide 
useful and predictive information about long term biological properties of MNPs including 
systemic, cellular, and genomic effects. Nano-bio interactions with human cells occur 
relatively rapidly, but the effects of these interactions (activation, production of free radicals, 
inflammation, etc.) are manifested over much longer time periods. However, the field of 
nanotechnology is creating new materials far too rapidly to make conventional toxicological 
testing feasible and/or practical. 
 (3) Toxicological data obtained from in-vitro cellular-based toxicity assays may 
correlate reasonably with in-vivo findings. It is too expensive, slow, and ethically 
questionable to use animal models to develop in vivo screening paradigm for hundreds of 
MNPs. In addition, to understand the toxicological implications of MNPs in the body, one 
would have to have a quantitative bioassay for each tested MNP. We propose to focus on 
liver toxicology, and specifically macrophages, to correlate key in vitro findings to in vivo 
implications. It relies on the well-known rapid accumulation of particles in liver 
macrophages, part of the reticuloendothelial system, as a mean to develop in vitro/in vivo 
correlations.  
 (4) Development of predictive Quantitative Nanostructure – Activity (QNAR) models 
using physical/chemical characterization and toxicological screens for an ensemble of MNPs. 
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QNTR models correlating descriptors derived from the structure and 
physical/chemical/geometrical properties of nanomaterials with some toxicological endpoints 
will allow the field to both prioritize existing MNPs for toxicity testing and to rationally 
design benign MNPs for various applications. 
Our approach addresses, both in the near- and long-term, a significant problem that 
exists in studying the biological activity, and especially, toxicity of nanoparticles. The 
problem relates to the complexity, time, and cost associated with performing sub-chronic and 
chronic toxicity studies of novel nanomaterials in animals [58]. Simply, these types of 
comprehensive studies are impossible. Thus, high-throughput cellular-based toxicity assays 
that provide critical and predictive data in just a few hours would be compelling. Moreover, 
using well-characterized key physical/chemical properties and structural parameters of 
nanoparticles, it would be possible to develop Quantitative Nanostructure-Toxicity 
Relationship (QNTRs) models to correlate these structural and physical/chemical descriptors 
of nanomaterials with a known toxicological endpoint. Similar to more traditional 
computational toxicology, these models can be used to predict toxicity of newly designed 
nanomaterials and bias the design and manufacturing towards safer products.  
In the case study, 109 nanoparticles composed of the same core structure but carrying 
diverse organic molecules on their surfaces were screened against different cell lines [51]. 
PaCa2 cell line was selected for in-depth QSAR study because of the suitable variance of 
cellular uptakes among all tested nanoparticles. Each individual particle was represented by 
the structure of the organic molecule attached to its surface. Statistically robust QSAR 
models linking chemical descriptors and NP cellular uptakes were developed and validated 
using 5-fold external validation procedure. 
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An important component of data collection and preliminary evaluation is the search 
for potential “signal” indicating the presence of implicit structure-activity relationships. We 
must stress that MNPs are complex chemical materials and before embarking on the huge 
task of predictive computational nanotoxicology, we had to prove that statistical and data-
mining techniques could indeed uncover the non-spurious nanostructure – activity 
correlations using measured properties of MNPs as structural descriptors. Our preliminary 
analysis of these two datasets provides a clear indication that our approach could indeed bear 
fruit. 
 In summary, the trends in experimental nanotechnology and nanotoxicology require 
not only to explore and rationalize the experimental nanostructure-toxicity relationships but, 
most importantly, develop models that will help both designing the environmentally benign 
nanomaterials and prioritize existing and developing MNPs for toxicity testing. Integrated 
data obtained from the characterization of the MNPs and the high-throughput cell-based 
toxicological screens could enable the development of predictive QNTR models to correlate 
descriptors with a toxicological endpoint.  
3.4. Conclusion 
Challenges of computational nanotoxicology are numerous. To establish robust and 
predictive models to accurately predict biological responses associated with a given 
nanoparticle, we have considered the Quantitative Nanostructure-Activity Relationships 
(QNAR) approach. Using limited available published data we have developed statistically 
robust QNAR models that can successfully predict the biological effects of NPs solely from 
their descriptors either experimentally measured or theoretically calculated. To increase both 
accuracy and impact of models on the experiments, we would need more systematic 
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experimental data (structural and biological) that can be used both to build and to validate 
computational models. Using this data, QNAR approaches will allow rational design or 
prioritization of novel NPs with desired target (physical and biological) properties. Such 
projects enable collaborations between specialists in nanotechnology and nanobiology, 
toxicology, cheminformatics and computer science. The unique blend of complimentary 
expertise needed to advance this new challenging field calls for the development of rigorous 
and extensible interdisciplinary framework that is bound to significantly create new forms of 
knowledge and advance the field of nanotoxicology. We also call for an intensified 
collaboratory between industrials and academic institutions willing to share their data: 
computational tools can clearly help collecting, mining and sharing valuable MNPs’ 
experimental data. 
  
 
 
 
Chapter 4.  
QNAR Modeling and Virtual Screening of CNTs for Benign Nanoparticles 
 
4.1. Introduction 
 This chapter continues the concept of the work in chapter 3 but takes it to a new level 
of innovation and sophistication. We carried on the work on modeling nanoparticles with the 
same core structure but different surface modification molecules which are called functional 
nanoparticles. In this case, we are studying the biological and toxicological properties of 
carbon nanotubes in various in vitro experimental settings.  
 Single-walled carbon nanotubes are hollow cylinders of carbon with diameters on the 
order of one nanometer, lengths ranging from tens of nanometers to centimeters, and walls 
that are one atomic-layer thick [31]. Like other nanomaterials, the properties of carbon 
nanotubes depend on their size and atomic structure. Carbon nanotubes have been widely 
studied for their potential application in biology and medicine. When injected into an animal, 
they enter various organs and cellular departments and bind to protein and DNA molecules. 
These properties offer functionalized nanotubes tremendous opportunities to function as 
intracellular probes, drug carriers, imaging agents, DNA modulators, and other medical 
devices on the condition that they are biocompatible. In general, the bioactivity of a 
nanomaterial is modulated by its surface chemistry, among other factors [59]. Single-walled 
carbon nanotubes modified by different types of organic molecules attached to their surfaces 
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were shown to have noticeably different cellular location and behavior in biological systems 
[60]. However, the lack of knowledge on the adverse effect of carbon nanotubes on 
biological systems and human has impeded the application of these materials. Some 
researchers are fundamentally against using nanomaterials in medicine and in the 
environment while others are in favor. The important point here is that because there are 
many nanomaterials with multiple different uses, it is difficult to test all of them and estimate 
their effects on human health. Therefore, some scientists believe that MNP side effects are 
acceptable. Considering all factors, testing the effects of nanomaterials on mammals and the 
environment is necessary. Only with more research, and using scientific evidence, 
microscopy tools, and modern analysis methods, can we discover the advantages or 
disadvantages of their applications. Currently, macrophage is one of the three in vitro 
systems that are widely used in the cytotoxicity evaluation of CNTs because of their 
relationship with respiratory, dermatological and immunological toxicity [61]. The toxicity 
results depend on the purity of CNT preparation and the assay method utilized.  
 In order to discover biologically benign nanotubes without a priori knowledge of the 
related targets or mechanism, our collaborators at St. Jude Children’s Hospital (Dr. Bing 
Yan’s group) recently decided to expose the biological targets of interest with the maximum 
surface structural diversity of nanotubes through combinatorial nanotube library synthesis 
[62]. The physicochemical properties of the surface molecules were calculated using in silico 
methods beforehand, and 80 molecules were chosen for chemical synthesis because their 
surface molecules have the most diverse molecular and physicochemical properties based on 
the computational results. These molecules were synthesized and attached onto the surface of 
CNTs’. The purity of the final products was rigorously tested to achieve the acceptable range. 
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The CNT library was then tested in various in vitro systems, including protein binding assays, 
acute toxicity assay, and immunotoxicity assay. And all the data generated was generously 
shared with us to enable computational analysis of the experimental data. 
Besides establishing statistically significant relationships between structural features 
of nanoparticles and their activities, we applied the developed models for virtually screening 
an in silico designed chemical library consisting of 240,000 molecules which were 
considered attachable to the surface of CNTs’ by our collaborators. Furthermore, the list 
containing top-scoring chemical hits was shared with our collaborators for experimental 
validation. The results of the experimental validation were then sent back to us for 
performance analysis. The workflow of this study is summarized in Figure 4.1. 
 
 
Figure 4-1 The workflow of QNAR model building, validation, virtual screening and 
experimental validation applied to the CNT dataset and in silico designed library. 
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4.2. Materials and Methods 
4.2.1. Data Source 
The data contains a series of 84 particles with the same core structure (MWNT, multi-
walled nanotube) but different surface modifications which are tested against six endpoints 
including protein binding (BSA, carbonic anhydrase (CA), chymotrypsin and hemoglobin), 
acute toxicity and immune toxicity [62]. Dataset was collected and formatted to enable 
subsequent descriptor calculation and model development according to standard dataset 
curation procedure [50]. Each CNT was represented by a single copy of its surface modifier, 
for which chemical descriptors (Dragon and MOE) have been calculated. Descriptor values 
were range-scaled across all CNTs so that the resulting values are from 0 to 1. In the case of 
multi-task learning, the joint activity matrix was formed by simply concatenating the 
experimental values (protein binding) of each endpoint into a single matrix. Thus, unlike 
STL the data matrix included descriptor columns as well as three target activity columns. 
4.2.2. Multi-task Learning Algorithm 
Multi-task learning is a special machine learning algorithm, which optimizes a model 
with respect to multiple target properties (unlike more common single task learning when the 
model is optimized to achieve the highest accuracy of prediction of the single target property). 
In QSAR/QNAR settings, MTL is useful in modeling relatively small and structurally 
diverse datasets tested in multiple assays. In this study, the dataset contains 84 CNTs with 
different surface modifiers that were tested in six different biological or toxicological assays 
(protein binding, acute toxicity, and immune toxicity). More specifically, CNTs were tested 
in bovine serum albumin, carbonic anhydrase, chymotrypsin and hemoglobin protein binding 
assays in vitro.  
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Figure 4-2 Virtual screening of external library result in virtual chemical hits which are 
considered as CA non-binders or non-toxic when attached to surface of CNTs’. (Courtesy of 
Dr. Denis Fourches) 
 
4.2.3. Virtual Screening 
 Statistically significant QNAR models were utilized to virtually screen an in silico 
designed library consisting of 240,000 molecules which are considered to be attachable to the 
surface of CNTs by our collaborators (Dr. Bing Yan’s group at St. Jude Children’s Research 
Hospital). The biological endpoints are Carbonic Anhydrase (CA) binding and acute toxicity. 
Each CNT was represented by a single copy of the attached chemical modifier. The 
workflow for virtual screening using QNAR models is shown in Figure 4.7. First, we used 
similarity search to decrease the number of candidates, where the non-binder of CA (or non-
toxic) CNTs were used as probes and structurally highly similar compounds were selected as 
potential hits for further consideration. We also used conservative applicability domain (AD) 
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to ensure the high reliability of top-ranked hits during prediction. AD is defined by applying 
a distance threshold such that an external compound is considered as out of AD if the average 
distance between this compound and any compound in the modeling set is greater than the 
distance threshold. Any compound falling out of AD is considered as not suitable to be 
predicted by current QNAR models. The final list of compounds predicted to have low/high 
CA binding and low/high toxicity was shared with our collaborators for experimental testing.   
4.2.4. Experimental Testing and Validation 
 Prioritized molecules were tested experimentally in CA binding and acute toxicity 
experiments by our collaborators. To validate the performance of QNAR models as well as 
the virtual screening procedure, we applied the threshold used in modeling set to classify 
CNTs as CA non-binders and binders or toxic and non-toxic. Then, summary statistics (e.g., 
predictive accuracy) was calculated and statistical test was performed to confirm the 
powerfulness of the result.  
4.3. Results and Discussion 
4.3.1. Pairwise Correlation of Protein Binding Profile 
 Before multi-task learning analysis, we checked the correlation among the endpoints 
that the models will be trained against, namely, BSA, CA, CT and HB protein binding. This 
is important since it will be difficult for the algorithm to learn a variety of tasks which are 
relatively independent with each other. By pair-wise comparison of different protein binding 
assays, we found that the results of CNT’s binding to CA, CT and HB are relatively highly 
correlated (Figure 4.2). However, CNT binding to HB had poor correlation with the other 
three proteins. Therefore, we trained the model to simultaneously learn CNT’s binding with 
CA, CT and HB.  
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Figure 4-3 84 CNTs were tested in four protein binding assays and pairwise correlations are 
shown. CA, CT and HB have reasonable correlation with each other, whereas BSA correlated 
poorly with other three proteins. 
 
4.3.2. Single-task and Multi-task Regression Analysis on Protein Binding Profile 
 QNAR models were constructed for three protein binding endpoints, HB, CA, and CT, 
using MTL approach (where models were trained towards multiple correlated protein binding 
endpoints simultaneously) in comparison with STL approach applied to each target 
independently. Continuous models were constructed using k nearest neighbor approach 
adapted to deal with MTL cases. The results of 5-fold external cross-validation are shown in 
comparison with the results from single-task learning approach (Figure 4.3). Apparently the 
results are mixed: none of the models had very high external predictive accuracy but some 
are statistically significant and acceptable. The latter (with R02 values of ca. 0.5) include  
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Figure 4-4 Plots of actual vs. predicted protein binding for the external datasets averaged 
over 5-fold external cross validation experiments for hemoglobin (HB), carbonic anhydrase 
(CA) and chymotrypsin (CT) binding using single-task learning (A, C, E) and multi-task 
learning (B, D, F). Coefficients of determination (regression through the origin: R02) are 
shown for each plot. 
 
(A) (B) 
STL 
(C) (D) 
(E) (F) 
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models for hemoglobin, HB (both STL and MTL) as well as chymotrypsin, CT (only MTL). 
No good models were generated for the carbonic anhydrase, CA.  Note that MTL provided 
no improvement vs. STL for both HB and CA but afforded very significant improvement in 
case of CT binding. 
4.3.3. Unsupervised Hierarchical Clustering Analysis 
 For qualitative SAR (structure-activity relationship) trend analysis, we utilized 
unsupervised hierarchical clustering analysis, which allows us to uncover the structural 
patterns in the dataset without using the labeling information. Chemical structures of surface 
modifiers were characterized with Dragon software. After the clustering analysis was 
completed, the result was combined with activity information. This analysis identified 
specific functional groups leading to high (or low) protein binding profile (Figure 4.4). BSA 
binding of CNTs correlated rather poorly with other protein binding of CNTs. Therefore, we 
have considered clusters of CNTs with consistent binding activity against CA, CT and HB. 
 
Figure 4-5 Unsupervised hierarchical clustering analysis uncovers important chemical 
functional groups that define whether a compound would have high or low protein binding 
profile. 
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Table 4-1 Summary of statistical results of QNAR modeling for CA binding. Combinatorial 
QNAR modeling was performed by combining a variety of machine learning techniques 
(kNN, SVM and RF) with different sets of chemical descriptors (Dragon and MOE). 
 
 
4.3.4. QNAR Classification Modeling for CA Binding and Acute Toxicity 
QNAR classification models for each individual biological endpoint were constructed using 
our standard workflow for predictive QSAR modeling [50]. Statistically significant models 
were developed for carbonic anhydrase (CA) binding (Table 4.1) and acute toxicity tested 
with WST-1 assay (Table 4.2). In case of CA binding, arbitrary activity threshold was chosen 
at 2.00 (F0/F1, F0 is the protein intrinsic fluorescence before CNT binding and F1 is the one 
after CNT binding). Thus, CNTs were grouped into two classes: CA binders and non-binders 
(Figure 4.5). Note that any CNT without surface modification is not considered for QNAR 
modeling. Combinatorial QNAR approach was applied; i.e., different individual  
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Table 4-2 Summary of statistical results of QNAR modeling for acute toxicity. 
Combinatorial QNAR modeling was performed by combining a variety of machine learning 
techniques (kNN, SVM and RF) with different sets of chemical descriptors (Dragon and 
MOE). 
 
 
machine learning techniques (kNN, SVM, RF) were combined with different sets of chemical 
descriptors (Dragon and MOE) to develop six types of QNAR models. Consensus prediction 
was applied during external prediction where final score of each compound is calculated by 
averaging the predictive values from all six QNAR models mentioned above. Calculated 
summary statistics from 5-fold external cross-validation is shown in Table 4.1. The 
cumulative external prediction accuracy was found to be as high as 75% in the case of kNN-
Dragon models. In case of acute toxicity, the arbitrary threshold was set at 40% survival  
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Figure 4-6 Distribution of CA binding of 84 CNTs in the dataset. Arbitrary threshold was 
chosen at 2.00 for classification purpose. 
 
percentage (Figure 4.5). Similar approaches were adopted as in the case of CA binding, and 
the cumulative external prediction accuracy was found to be as high as 77% (Table 4.2). 
 
Figure 4-7 Distribution of acute toxicity tested in WST-1 assay for 84 CNTs in the dataset. 
Arbitrary threshold was chosen at 0.40 for classification purpose. CNTs with survival 
percentage between 0.38 and 0.42 are considered as marginally toxic or non-toxic and were 
removed before modeling. 
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4.3.5. Virtual Screening of a Chemical Library Consisting of 240, 000 Molecules 
 Statistically significant QNAR models have been developed for a series of CNTs 
against multiple toxicological endpoints (CA binding and acute toxicity). QNAR models with 
acceptable external predictivity (prediction accuracy>70%) were used for virtual screening. 
In silico designed library containing 240,000 chemicals proposed by the collaborating 
experimental group (Bing Yan’s group at St. Jude children’s research hospital) was screened, 
seeking for CA non-binders and non-toxic CNTs (Figure 4.6). First, we used similarity 
search to decrease the number of candidates, where the non-binder of CA (or non-toxic) 
CNTs were used as probes and structurally highly similar compounds were selected as 
potential hits for further consideration. We also used conservative applicability domain (AD) 
to ensure the high reliability of top-ranked hits during prediction. AD is defined by applying 
a distance threshold such that an external compound is considered as out of AD if the average 
distance between this compound and any compound in the modeling set is greater than the 
distance threshold. Any compound falling out of AD is considered as not suitable to be 
predicted by current QNAR models. Final hit list containing around 30 chemicals for each 
endpoint was sent to the Dr. Yang’s group for experimental testing 
4.3.5. Experimental Testing and Validation of High-Score Hits 
 Prioritized molecules were tested experimentally in CA binding and acute toxicity 
experiments by our collaborators (Dr. Bing Yan’s group).  
For acute toxicity endpoint, 10 toxic and 10 non-toxic hits (predicted by 
computational models) were tested in WST-1 assay. The cytotoxicity of each CNT was tested 
in THP-1 cells in quadruplicate. The statistical test (one sided student’s t-test) (p<0.0001) 
showed that average cell viability of non-toxic hits was significantly higher than that of toxic 
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hits. Moreover, all predicted non-toxic CNTs have higher survival percentage compared with 
that of predicted toxic CNTs.  
Similarly, 10 CA binders and 10 non-binders (also predicted by computational 
models) were tested using in vitro protein binding assays. Each CNT was tested in duplicates.  
To calculate the summary statistics (e.g., predictive accuracy), threshold used in modeling set 
was applied to classify CNTs as CA non-binders and binders or toxic and non-toxic. Note 
that one of CNTs in the modeling set was re-tested in order to normalize the surface density. 
The calculated statistics are shown in Tables 4.3 and 4.4. Briefly, for acute toxicity endpoint, 
all 10 CNTs predicted to be non-toxic are verified as non-toxic, and 6 out of 10 CNTs 
predicted to be toxic are verified as toxic (total accuracy 80%). For CA binding endpoint, all 
10 CNTs predicted as binders are verified as binders, and 7 out of 10 CNTs which are 
predicted to be non-binders are verified as non-binders (total accuracy 85%).  
Table 4-3 Summary of experimental validation results for cytotoxicity of selected hits. 
Threshold of 40% was applied to classify CNTs as non-toxic or toxic. CNTs are labeled as “0” 
(non-toxic) if their cell viability are greater than 40% and “1” (toxic) if their cell viability are 
smaller than 40%. The calculated statistics showed that sensitivity=100% (6/6), 
specificity=71% (10/14), prediction accuracy=80% (16/20). 
 
CNT ID II-1 II-2 II-3 II-4 II-5 II-6 II-7 II-8 II-9 II-10 
Average cell viability (%) 48 51 51 46 48 55 58 62 58 49 
Standard Deviation (%) 5 3 3 3 2 10 6 7 3 6 
Class 0 0 0 0 0 0 0 0 0 0 
Predicted Class 0 0 0 0 0 0 0 0 0 0 
CNT ID II-11 II-12 II-13 II-14 II-15 II-16 II-17 II-18 II-19 II-20 
Average cell viability (%) 29 39 36 39 42 31 41 39 45 40 
STDEV (%) 9 8 7 5 8 11 5 9 11 10 
Class 1 1 1 1 0 1 0 1 0 0 
Predicted Class 1 1 1 1 1 1 1 1 1 1 
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Table 4-4 Summary of experimental validation results for selected CA binders and non-
binders. The threshold was set at 2.00 (F0/F1) in the modeling process, and CNTs are labeled 
as “0” (non-binder) if their CA bindings are smaller than 2.00 and “1” (binder) if their CA 
bindings are greater than 2.00. Calculated sensitivity is 77% (10/13), specificity is 100% (7/7) 
and prediction accuracy is 85% (17/20). 
 
CNT ID II-21 II-22 II-23 II-24 II-25 II-26 II-27 II-28 II-29 II-30 
Average protein binding (F0/F1) 1.68 1.66 1.92 1.72 1.83 2.60 1.74 2.01 1.60 2.65 
Standard Deviation  0.05 0.06 0.02 0.03 0.02 0.02 0.02 0.01 0.06 0.02 
Class 0 0 0 0 0 1 0 1 0 1 
Predicted Class 0 0 0 0 0 0 0 0 0 0 
CNT ID II-31 II-32 II-33 II-34 II-35 II-36 II-37 II-38 II-39 II-40 
Average protein binding (F0/F1) 4.29 2.78 2.48 2.51 2.59 3.69 2.37 2.77 3.41 2.90 
STDEV  0.03 0.05 0.08 0.01 0.04 0.00 0.02 0.06 0.05 0.11 
Class 1 1 1 1 1 1 1 1 1 1 
Predicted Class 1 1 1 1 1 1 1 1 1 1 
 
4.4. Conclusions 
This study presents the first example of a non-proprietary investigation when the 
complete cycle of initial data generation, QNAR model building, model exploitation for 
virtual screening and computational hit identification, and experimental hit validation was 
successfully realized in the area of nanotoxicity screening.  The experimental data was 
initially retrieved from literature by searching in the public database (e.g., pubmed) and 
subsequently compiled to be appropriate for cheminformatic and QNAR analysis. By 
simplifying the system from modeling complex nanoparticle to modeling organic molecules, 
we were able to apply classic QSAR methods to search for underlying principles that relates 
the structural features of nanoparticles with their biological and toxicological behavior in in 
vitro testing system.  
Unsupervised clustering analysis uncovers the functional groups on the surface of 
CNTs’ which are important for their protein binding properties. Subsequent quantitative 
modeling analysis not only generates statistically significant QNAR models, but also enables 
virtually prioritizing compounds for experimental testing. The high agreement between 
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virtually screened hits and their experimental testing results validates the effectiveness of our 
research methods. Our proof-of-concept studies suggest that QNAR models are indeed 
extremely useful for rational discovery of CNTs with the desired properties (i.e., reduced 
toxicity and low protein binding). 
  
 
 
 
 
 
Chapter 5.  
 
Conclusions and Future Directions 
 
5.1. Quantitative Structural-Activity Relationship Modeling of Skin Sensitization Tested by 
Local Lymph Node Assay 
 Although skin diseases may not be fatal, they severely interfere with people’s normal 
life and decrease the living quality of the patients. Moreover, the cost for accurately testing 
the skin toxicity potential of compounds using animal models is extremely high. According 
to the NIEHS report on testing skin toxicity of chemicals [20], the standard protocol has been 
changed from three dose points to only one maximum dose point in order to reduce the cost 
of testing as well as animal ethic. Therefore, it calls for the development of rigorous and 
applicable computational tools for forecasting the toxicity potential of small chemicals. 
Previous studies have been carried out to achieve this goal, however with obvious flaws 
either from limited chemical space coverage or low prediction performance.  
At the time when this study was performed, it was the most comprehensive 
computational modeling study on skin sensitization endpoint. We retrieved and compiled the 
largest dataset consisting of 409 compounds tested in local lymph node assay. The 
compounds in the dataset cover a great amount of chemical space with obvious clusters 
representing a variety of different underlying mechanisms. By removing compounds which 
were considered structurally significantly different from the major cluster of compounds, the 
QSAR models afford predictive accuracy as high as 83%, for both kNN and RF algorithms, 
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which was one of highest among all relevant studies. Moreover, applicability domain of 
QSAR models was explicitly defined for each algorithm to avoid arbitrary extrapolation of 
the predictions for compounds whose structural scaffolds were noticeably different from the 
training set compounds. 
Besides developing and validating theoretical computational models with existing 
data, we also applied the statistically significant models to an external dataset which was 
obtained from a public website. The performance was validated on the non-overlapping 
portion of the external data. The prediction accuracy was as high as 75%. This proves the 
practical usefulness of our models, which was the ultimate target of every QSAR study.  
 According to the OECD standards for performing QSAR studies, besides reporting 
acceptable value of statistical metric (i.e., residual sum of square), each study needs sound 
mechanistic interpretation of the computational models, which will relate the 
physicochemical properties of compounds to the target activity of interest. In this case, we 
analyzed the relative importance of chemical descriptors used in each computational model. 
In fact, many descriptors involved with the presence of electron-depleting groups were found 
most frequently appeared in the statistically significant models. This also conforms to 
previous findings that the presence of electron-depleting groups on small molecules is critical 
for conjugation reaction to occur with proteins.  
5.2. QNAR Modeling and Virtual Screening of MNPs for Biologically Benign Nanoparticles 
 Chapters 3 and 4 focus on applying QSAR philosophy to model complex nanoparticle 
system trying to understand as well as predict their behavior in biological settings. 
Nanoparticles exert special properties compared to their larger-sized analogues because of 
their size. Manufactured nanoparticles refer to a category of nanoparticles were specifically 
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engineered to achieving certain special properties, mostly attractive to practical use of human 
beings. However, the safety concerns of MNPs only came in attention during the last 5-10 
years when there was a major boom in the application of nanotechnology in nearly every 
field, ranging from energy source to cosmetics. The experimental evaluation of toxicity of 
nanoparticles is costly and time-consuming, calling for the development of efficient 
computational tools capable of predicting biological events caused by MNPs from their 
structural and physical chemical properties. However, three major obstacles impeded the 
improvement in modeling nanoparticles: (1) the availability of large scale datasets, which 
reflects the lack of sufficient attention on experimentally evaluating the toxicity of 
nanoparticles; (2) structural complexity of nanoparticles, which adds a significant layer of 
difficulty in modeling these substances; (3) lack of computational tools in describing the 
structural properties of nanoparticles, which result from both the lack of attention in this field 
and the complexity of the structures. Obviously, close collaboration between experimental 
and computational scientists would facilitate the process of filling the data gap. Data sharing 
among research laboratories and institutions is equally important in creating large scale 
datasets for computational studies.  
 Aiming at trying to resolve the above issues in the field of nanotoxicity, chapter 3 
carried out the first ever systemic study on computational modeling of nanoparticles as a 
proof-of-concept. A library of 109 nanoparticles (cross-linked iron oxide with amine groups) 
decorated with different synthetic small molecules was shared with us by our experimental 
collaborators at Broad Institute of Harvard and MIT. It was proposed that the surface 
chemistry of nanoparticles may be critical in determining the in vitro and in vivo behavior of 
nanoparticles. The library of nanoparticles was tested in several in vitro cell lines and the 
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results with human pancreatic cancer cell showed the most variability and were considered 
most suitable for QSAR modeling. Regression analysis using parameters describing the 
structural features of surface molecules demonstrated acceptable statistical results. This was 
further validated by 5-fold external cross-validation and y-randomization procedure. 
Chemical descriptors with most discriminative power were also picked up and provided 
insights into the mechanism of action of nanoparticles. However, we were not able to have a 
chance to test the computational models against other datasets for experimental validation. 
 To further prove our working philosophy and modeling workflow, chapter 4 describes 
a study with similar concepts as Chapter 3, but with additional virtual screening exercise and 
experimental testing of virtual hits. In the case, we were collaborating with Dr. Yan’s group 
from St. Jude Children’s Research Hospital in terms of data sharing, model development, 
virtual screening and experimental validation. Similarly, 84 carbon nanotubes (CNT) were 
decorated with different surface chemicals. These are so-called functional CNTs. It was 
proposed that the surface change of CNTs will alter their biological and toxicological profiles. 
In this case, not only were statistically significantly models built, but these models were also 
applied to screen an external library (also shared by Dr. Yan’ group) containing 240,000 
small molecules which are considered attachable to the surface of CNTs. The virtual hits 
were again sent to collaborators for experimental testing. The final analysis on the testing 
results indicated that our models are powerful in discriminating protein binders and non-
binders as well as toxic and non-toxic CNTs.  
 In these two studies, we have established the workflow incorporating collaborative 
relationship with an experimental group for data sharing and experimental testing to virtual 
screening of in silico designed library for biologically benign nanoparticles. Due to the huge 
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amount of resources needed for this or even larger scale of studies, we anticipate that more 
and more opportunities will stem from collaboration between a relatively large number of 
laboratories and institutions.  
 Regarding the technical improvement needed to boost the performance of models of 
this sort, we need more comprehensive tools to describe the structural features of 
nanoparticles, besides surface chemistry. For instance, shape, size distribution and zeta 
potential are among many features which have also been considered major contributors to 
nanoparticles’ biological behavior. By taking into account the surface chemistry, we were 
able to explain the biological variability to a certain degree. However, to achieve the goal of 
incorporating computational models as an official operating procedure in evaluating the 
biological or toxicological profile of nanoparticles, more structural information needs to be 
gathered.  
 In summary, the chief contribution of this work is the demonstration that predictive 
modeling of nanoparticles in terms of relating their properties to their biological effects is 
feasible. We hope that this study is promoting collaborative relationship between 
experimental and modeling scientists to enable more comprehensive studies on identifying 
behavioral properties of nanoparticles in biological environment.  
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